Literature DB >> 2582448

Characterization of two cell lines with distinct phenotypes and genotypes established from a patient with renal cell carcinoma.

T Hashimura1, R R Tubbs, R Connelly, M J Caulfield, C S Trindade, J T McMahon, T P Galetti, M Edinger, A A Sandberg, P Dal Cin.   

Abstract

Two human renal carcinoma cell lines have been established from the same patient. One cell line (CCF-RC1) was obtained from the primary tumor and the second (CCF-RC2) was established from cells of the renal vein effluent of the perfused tumorous kidney. Although they were established from the same patient, the cell lines differed in certain biological properties. They have been passaged up to 50 times in vitro for about two years. Each has an epithelial morphology and exhibits mutilayering. Cell cycle time of CCF-RC1 and CCF-RC2 was 34 and 36 h, respectively. They exhibited anchorage independent growth, and the plating efficiency of CCF-RC2 in soft agar was higher than that of CCF-RC1. Both lines induced tumors in nude mice at the site of s.c. injection closely resembling the original tumor in histological examination. Electron microscopic features of both tumors in nude mice were consistent with epithelial origin. Doubling time of CCF-RC1 and CCF-RC2 in nude mice was 11 and 12 days, respectively. CCF-RC1 and CCF-RC2 have hypotetraploid karyotype and modal numbers of 83 and 73, presenting two and three marker chromosomes, respectively. Immunocytology with commercial monoclonal antibodies against renal carcinoma (URO-3) and cytokeratin (Mac 6) showed positive reactions with both lines, suggesting that these cell lines derived from renal epithelium. A murine monoclonal antibody (2E11) was generated against CCF-RC2 by the hybridoma technique; 2E11 reacted with CCF-RC2, but not with CCF-RC1. These cell lines may provide a useful model for the study of tumor heterogeneity and its relationship to metastasis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2582448

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  The role of NF-kappaB in the regulation of the expression of wilms tumor suppressor gene WT1.

Authors:  Y Chen; B R Williams
Journal:  Gene Expr       Date:  2000

2.  Simplified cryopreservation of mammalian cell lines.

Authors:  A K Saxena; S Ramchandani; A Dwivedi; R Sharma; V K Bajpai; K R Bhardwaj; A K Balapure
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-05       Impact factor: 2.416

3.  Adhesion of renal carcinoma cells to endothelial cells depends on PKCmu.

Authors:  Walburgis Brenner; Silke Beitz; Elke Schneider; Frank Benzing; Ronald E Unger; Frederik C Roos; Joachim W Thüroff; Christian Hampel
Journal:  BMC Cancer       Date:  2010-05-06       Impact factor: 4.430

4.  Inflammatory cell infiltrate in a responding metastatic nodule after vaccine-based immunotherapy.

Authors:  T F Logan; B Banner; U Rao; M S Ernstoff; N Wolmark; T L Whiteside; L Miketic; J M Kirkwood
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

5.  Establishment and characterization of five new human renal tumor xenografts.

Authors:  A J Beniers; W P Peelen; H E Schaafsma; J L Beck; F C Ramaekers; F M Debruyne; J A Schalken
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

6.  A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor.

Authors:  A Schoenfeld; E J Davidowitz; R D Burk
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

7.  Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma.

Authors:  G G Hillman; R K Puri; M A Kukuruga; J E Pontes; G P Haas
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

8.  Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest.

Authors:  Julian J Raffoul; Yu Wang; Omer Kucuk; Jeffrey D Forman; Fazlul H Sarkar; Gilda G Hillman
Journal:  BMC Cancer       Date:  2006-04-26       Impact factor: 4.430

9.  ADAM17 is a survival factor for microglial cells in vitro and in vivo after spinal cord injury in mice.

Authors:  P M Vidal; E Lemmens; A Avila; T Vangansewinkel; A Chalaris; S Rose-John; S Hendrix
Journal:  Cell Death Dis       Date:  2013-12-12       Impact factor: 8.469

10.  Interleukin-25 is detrimental for recovery after spinal cord injury in mice.

Authors:  Dearbhaile Dooley; Evi Lemmens; Peter Ponsaerts; Sven Hendrix
Journal:  J Neuroinflammation       Date:  2016-05-06       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.